GAPDH and B-cell chronic lymphocytic leukemia: In vivo studies also confirm that ceramide is targeting GAPDH in CLL, as protein isolated from tumor tissue showed an overall decrease in GAPDH expression following treatment with C6-ceramide nanoliposomes.